MMJ Biopharma Cultivation

Mmj Biopharma Cultivation

Pharmaceuticals, 330 3rd St S, Saint Petersburg, Florida, 33701, United States, 1-10 Employees

mmjbiopharmacultivation.com

  • LinkedIn

phone no Phone Number: +14*********

Who is MMJ BIOPHARMA CULTIVATION

MMJ BioPharma Cultivation, is the premier US medical cannabis cultivation and research company. MMJ BioPharma Cultivations mission is rooted in unlocking the potential of cannabinoid medi...

Read More

map
  • 330 3rd St S, Saint Petersburg, Florida, 33701, United States Headquarters: 330 3rd St S, Saint Petersburg, Florida, 33701, United States
  • 2016 Date Founded: 2016
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: Under $1 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Pharmaceuticals

SIC SIC Code: 1521

checked-icon Does something look wrong? Fix it. | View contact records from MMJ BIOPHARMA CULTIVATION

MMJ Biopharma Cultivation Org Chart and Mapping

Employees

Erica Kollmann

Clinical Development Coordinator

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding MMJ Biopharma Cultivation

Answer: MMJ Biopharma Cultivation's headquarters are located at 330 3rd St S, Saint Petersburg, Florida, 33701, United States

Answer: MMJ Biopharma Cultivation's phone number is +14*********

Answer: MMJ Biopharma Cultivation's official website is https://mmjbiopharmacultivation.com

Answer: MMJ Biopharma Cultivation's revenue is Under $1 Million

Answer: MMJ Biopharma Cultivation's SIC: 1521

Answer: MMJ Biopharma Cultivation has 1-10 employees

Answer: MMJ Biopharma Cultivation is in Pharmaceuticals

Answer: MMJ Biopharma Cultivation contact info: Phone number: +14********* Website: https://mmjbiopharmacultivation.com

Answer: MMJ BioPharma Cultivation, is the premier US medical cannabis cultivation and research company. MMJ BioPharma Cultivations mission is rooted in unlocking the potential of cannabinoid medicines to address serious medical conditions with limited treatment options. Unlike companies dealing with medical marijuana in states where it is federally illegal, MMJ BioPharma Cultivation has applied for a Drug Enforement Administration Schedule-I Bulk Manufacturer registration to cultivate plants for Food and Drug Administration approved medicines. MMJ BioPharma Cultivation will facilitate a process of scientific drug development and discovery governed by FDA protocol development processes, intellectual property portfolio and DEA regulatory manufacturing guidelines. MMJ is a biopharmaceutical company with a pioneering cannabis formulation (a prescribed pharmaceutical) of CBD (Cannabidiol)+THC (Tetrahydrocannabinol) via purified botanical extract. MMJ will be producing a targeted, personalized dose, of non-addictive, FDA-approved motor cortex and pain management drug as an alternative to the opiates. Once approved by the DEA, MMJ BioPharma Cultivation will be one of the first harvesters of cannabis plants to conduct a unique pharmaceutical research and development program into the medicinal uses of cannabis. Sowing will commence as soon as permitted, and the initial crop of 5,000 plants will be grown in a climate-controlled building at a secure research facility.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access